Depression Treatment among Adults with Multiple Sclerosis and Depression in Ambulatory Care Settings in the United States
Table 1
Demographic and clinical characteristics of adults with MS and depression (NAMCS-NHAMCS 2005–2011).
Characteristics
Unweighted freq
Wt. freq (millions)
Wt.%
Predisposing factors
Age
18–39
50
0.325
15.45
40
170
1.778
84.55
Gender
Male
51
0.501
23.80
Female
169
1.604
76.20
Race/ethnicity
White Only, NH
172
1.873
89.00
Others
48
0.232
11.00
Geographic region
West
37
0.320
15.21
Northeast
56
0.407
19.35
Midwest
63
0.754
35.82
South
64
0.623
29.62
Metro status
Metro
204
1.864
88.60
Nonmetro
16
0.240
11.41
Enabling factors
Insurance
Govt. insurance
97
0.735
34.93
Others
123
1.369
65.08
Physician/clinic specialty
Gen & fam prac
42
0.639
30.39
Others
178
1.465
69.61
Need factors
Reason visit
Chron prob/routine
143
1.024
48.68
Others
77
1.080
51.32
New prescription during visit
Yes
65
0.552
26.22
No
155
1.552
73.78
Disease modifying drugs
Yes
81
0.570
27.11
No
139
1.534
72.89
Chronic diseases
ARTHRITIS
20
0.369
17.53
ASTHMA
9
0.037
1.78
CANCER
7
0.069
3.27
CHF
2
0.031
1.48
COPD
5
0.183
8.70
DIABETES
17
0.171
8.14
HYPLIPID
33
0.400
19.03
HTN
49
0.725
34.47
IHD
3
0.045
2.11
ANXIETY
3
0.039
1.85
Note. Based on 220 (nationally representative weighted million) ambulatory visits of adults (age ≥ 18 years) with Multiple Sclerosis and depression using NAMCS and NHAMCS 2005–2011 data. MS: Multiple Sclerosis; NAMCS: National Ambulatory Medical Care Survey; NHAMCS: National Hospital Ambulatory Medical Care Survey; Wt.: weighted; freq: frequency; NH: Non-Hispanic; Gen & fam prac: general and family practice; Govt: government; Chron prob: chronic problem; Estab: established; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; HYPLIPID: hyperlipidemia; HTN: hypertension; IHD: ischemic heart disease.
